Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)

AIM: To investigate the efficacy and safety of evogliptin compared with linagliptin in patients with type 2 diabetes. MATERIALS AND METHODS: In this 12‐week, multicentre, randomized, double‐blind, active‐controlled, and 12‐week open‐label extension study, a total of 207 patients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gyuri, Lim, Soo, Kwon, Hyuk‐Sang, Park, Ie B., Ahn, Kyu J., Park, Cheol‐Young, Kwon, Su K., Kim, Hye S., Park, Seok W., Kim, Sin G., Moon, Min K., Kim, Eun S., Chung, Choon H., Park, Kang S., Kim, Mikyung, Chung, Dong J., Lee, Chang B., Kim, Tae H., Lee, Moon‐Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496811/
https://www.ncbi.nlm.nih.gov/pubmed/32319168
http://dx.doi.org/10.1111/dom.14061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496811/
https://www.ncbi.nlm.nih.gov/pubmed/32319168
http://dx.doi.org/10.1111/dom.14061

Ejemplares similares